PortfoliosLab logoPortfoliosLab logo
DOCT.L vs. WHCE.L
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

DOCT.L vs. WHCE.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in L&G Healthcare Breakthrough UCITS ETF (DOCT.L) and Invesco S&P World Health Care ESG UCITS ETF Acc (WHCE.L). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

DOCT.L vs. WHCE.L - Yearly Performance Comparison


2026 (YTD)202520242023
DOCT.L
L&G Healthcare Breakthrough UCITS ETF
-9.59%24.88%1.98%-7.38%
WHCE.L
Invesco S&P World Health Care ESG UCITS ETF Acc
-6.06%15.94%1.55%2.96%

Returns By Period

In the year-to-date period, DOCT.L achieves a -9.59% return, which is significantly lower than WHCE.L's -6.06% return.


DOCT.L

1D
1.15%
1M
-8.10%
YTD
-9.59%
6M
4.21%
1Y
19.82%
3Y*
3.20%
5Y*
-5.82%
10Y*

WHCE.L

1D
1.17%
1M
-9.02%
YTD
-6.06%
6M
6.86%
1Y
3.20%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


DOCT.L vs. WHCE.L - Expense Ratio Comparison

DOCT.L has a 0.49% expense ratio, which is higher than WHCE.L's 0.18% expense ratio.


Return for Risk

DOCT.L vs. WHCE.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DOCT.L
DOCT.L Risk / Return Rank: 4747
Overall Rank
DOCT.L Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
DOCT.L Sortino Ratio Rank: 5555
Sortino Ratio Rank
DOCT.L Omega Ratio Rank: 4545
Omega Ratio Rank
DOCT.L Calmar Ratio Rank: 4444
Calmar Ratio Rank
DOCT.L Martin Ratio Rank: 4040
Martin Ratio Rank

WHCE.L
WHCE.L Risk / Return Rank: 1616
Overall Rank
WHCE.L Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
WHCE.L Sortino Ratio Rank: 1515
Sortino Ratio Rank
WHCE.L Omega Ratio Rank: 1515
Omega Ratio Rank
WHCE.L Calmar Ratio Rank: 1717
Calmar Ratio Rank
WHCE.L Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DOCT.L vs. WHCE.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G Healthcare Breakthrough UCITS ETF (DOCT.L) and Invesco S&P World Health Care ESG UCITS ETF Acc (WHCE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DOCT.LWHCE.LDifference

Sharpe ratio

Return per unit of total volatility

0.96

0.18

+0.78

Sortino ratio

Return per unit of downside risk

1.46

0.37

+1.09

Omega ratio

Gain probability vs. loss probability

1.18

1.05

+0.13

Calmar ratio

Return relative to maximum drawdown

1.16

0.26

+0.91

Martin ratio

Return relative to average drawdown

3.81

0.62

+3.19

DOCT.L vs. WHCE.L - Sharpe Ratio Comparison

The current DOCT.L Sharpe Ratio is 0.96, which is higher than the WHCE.L Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of DOCT.L and WHCE.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


DOCT.LWHCE.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.96

0.18

+0.78

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.24

Sharpe Ratio (All Time)

Calculated using the full available price history

0.17

0.33

-0.16

Correlation

The correlation between DOCT.L and WHCE.L is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

DOCT.L vs. WHCE.L - Dividend Comparison

Neither DOCT.L nor WHCE.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DOCT.L vs. WHCE.L - Drawdown Comparison

The maximum DOCT.L drawdown since its inception was -57.55%, which is greater than WHCE.L's maximum drawdown of -20.11%. Use the drawdown chart below to compare losses from any high point for DOCT.L and WHCE.L.


Loading graphics...

Drawdown Indicators


DOCT.LWHCE.LDifference

Max Drawdown

Largest peak-to-trough decline

-57.55%

-20.11%

-37.44%

Max Drawdown (1Y)

Largest decline over 1 year

-17.02%

-11.39%

-5.63%

Max Drawdown (5Y)

Largest decline over 5 years

-55.82%

Current Drawdown

Current decline from peak

-36.74%

-9.02%

-27.72%

Average Drawdown

Average peak-to-trough decline

-28.93%

-5.95%

-22.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.20%

4.29%

+0.91%

Volatility

DOCT.L vs. WHCE.L - Volatility Comparison

L&G Healthcare Breakthrough UCITS ETF (DOCT.L) has a higher volatility of 6.84% compared to Invesco S&P World Health Care ESG UCITS ETF Acc (WHCE.L) at 4.98%. This indicates that DOCT.L's price experiences larger fluctuations and is considered to be riskier than WHCE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


DOCT.LWHCE.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.84%

4.98%

+1.86%

Volatility (6M)

Calculated over the trailing 6-month period

14.24%

9.76%

+4.48%

Volatility (1Y)

Calculated over the trailing 1-year period

21.71%

17.45%

+4.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.85%

13.59%

+10.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.69%

13.59%

+11.10%